Since NLRP3 inflammasome is considered a pivotal player in the progression of NAFLD (Wan et al., 2016), combined with the above evidence, it was hypothesized that gardenoside might regulate the pathogenesis of NAFLD via NLRP3 and its downstream targets. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.